ArticleAmerican journal of cancer research2016

Rapamycin inhibits prostate cancer cell growth through cyclin D1 and enhances the cytotoxic efficacy of cisplatin.

Ahmet Imrali et al.PubMed ↗Full text ↗

No numbers read from the abstract.